GH1 and pseudopseudohypoparathyroidism: Because of the overlap between the clinical and biochemical features of different PHP subtypes, accurate diagnosis requires a careful molecular and epigenetic analysis of GNAS. Furthermore, two patients were affected by PHP1a and PPHP and were treated with growth hormone (GH) therapy, which provide new data for GH therapy in PHP patients without GH deficiency.